Therapeutic implications and mechanisms of angiogenesis : inhibitors and stimulators / editor, Wendy Hori

Contributor(s): Series: IBC's library seriesPublication details: San Francisco, CA. : International Business Communications, c1996Description: xv, (various pagings) : ill. ; 28 cmSubject(s): DDC classification:
  • WG 502 T398 1996
Contents:
Contents Section I: Models and mechanisms of angiogenesis Chapter 1.1: Angiogenesis in physiologic and pathologic processes: orchestration by cells, soluble mediators and matrix molecules Chapter 1.2: Quantification of angiogenesis inhibitors in animal models Chapter 1.3: Angiogenesis assays: problems, pitfalls and potentials Chapter 1.4: Mechanism of wound angiogenesis Chapter 1.5: Novel and potent antigenic lipids which promote skin graft survival Chapter 1.6: Yolk sac endothelial stem cells and the del-1 gene: recent discoveries in angiogenesis and potential therapeutic applications Section II: Angiogenic mechanisms as potential therapeutic targets in cancer, ocular, inflammatory and cardiovascular diseases Chapter 2.1: What targets, what endpoints for angiogenic modulation? Chapter 2.2: Repression of vascular endothelial growth factor gene expression by von Hippel-Lindau Tumor suppressor Protein Chapter 2.3: High angiogenic factor production in human melanoma xenografts is associated with a high vascular density Chapter 2.4: Flk-1 Antagonists for inhibition of angiogenesis Chapter 2.5: Identifying inhibitors of receptor / ligand interactions involved in angiogenesis Chapter 2.6: Angiogenesis in chronic inflammation Chapter 2.7: Regulation of endothelial cell growth by thrombospondin-1 and lysophosphatidic acid, two products of activated platelets
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Book Open Access Book Open Access Health Sciences Library WG 502 T398 1996 (Browse shelf(Opens below)) 1 Available MBAL22040448

Includes references

Contents

Section I: Models and mechanisms of angiogenesis
Chapter 1.1: Angiogenesis in physiologic and pathologic processes: orchestration by cells, soluble mediators and matrix molecules
Chapter 1.2: Quantification of angiogenesis inhibitors in animal models
Chapter 1.3: Angiogenesis assays: problems, pitfalls and potentials
Chapter 1.4: Mechanism of wound angiogenesis
Chapter 1.5: Novel and potent antigenic lipids which promote skin graft survival
Chapter 1.6: Yolk sac endothelial stem cells and the del-1 gene: recent discoveries in angiogenesis and potential therapeutic applications

Section II: Angiogenic mechanisms as potential therapeutic targets in cancer, ocular, inflammatory and cardiovascular diseases
Chapter 2.1: What targets, what endpoints for angiogenic modulation?
Chapter 2.2: Repression of vascular endothelial growth factor gene expression by von Hippel-Lindau Tumor suppressor Protein
Chapter 2.3: High angiogenic factor production in human melanoma xenografts is associated with a high vascular density
Chapter 2.4: Flk-1 Antagonists for inhibition of angiogenesis
Chapter 2.5: Identifying inhibitors of receptor / ligand interactions involved in angiogenesis
Chapter 2.6: Angiogenesis in chronic inflammation
Chapter 2.7: Regulation of endothelial cell growth by thrombospondin-1 and lysophosphatidic acid, two products of activated platelets

There are no comments on this title.

to post a comment.